Follow
Daniela Rinaudo
Daniela Rinaudo
Senior scientist at gsk
Verified email at novartis.com
Title
Cited by
Cited by
Year
Identification of a universal Group B streptococcus vaccine by multiple genome screen
D Maione, I Margarit, CD Rinaudo, V Masignani, M Mora, M Scarselli, ...
Science 309 (5731), 148-150, 2005
6672005
Complete genome sequence and comparative genomic analysis of an emerging human pathogen, serotype V Streptococcus agalactiae
H Tettelin, V Masignani, MJ Cieslewicz, JA Eisen, S Peterson, ...
Proceedings of the National Academy of Sciences 99 (19), 12391-12396, 2002
5832002
Genome analysis reveals pili in Group B Streptococcus
P Lauer, CD Rinaudo, M Soriani, I Margarit, D Maione, R Rosini, ...
Science 309 (5731), 105-105, 2005
3882005
Identification of novel genomic islands coding for antigenic pilus‐like structures in Streptococcus agalactiae
R Rosini, CD Rinaudo, M Soriani, P Lauer, M Mora, D Maione, A Taddei, ...
Molecular microbiology 61 (1), 126-141, 2006
2742006
Preventing bacterial infections with pilus-based vaccines: the group B streptococcus paradigm
I Margarit, CD Rinaudo, CL Galeotti, D Maione, C Ghezzo, E Buttazzoni, ...
Journal of Infectious Diseases 199 (1), 108-115, 2009
2662009
Vaccinology in the genome era
CD Rinaudo, JL Telford, R Rappuoli, KL Seib
The Journal of clinical investigation 119 (9), 2515-2525, 2009
2092009
Vaccine composition formulated with a novel TLR7-dependent adjuvant induces high and broad protection against Staphylococcus aureus
F Bagnoli, MR Fontana, E Soldaini, RPN Mishra, L Fiaschi, E Cartocci, ...
Proceedings of the National Academy of Sciences 112 (12), 3680-3685, 2015
1972015
Structure-based approach to rationally design a chimeric protein for an effective vaccine against Group B Streptococcus infections
A Nuccitelli, R Cozzi, LJ Gourlay, D Donnarumma, F Necchi, N Norais, ...
Proceedings of the National Academy of Sciences 108 (25), 10278-10283, 2011
1742011
Specific involvement of pilus type 2a in biofilm formation in group B Streptococcus
CD Rinaudo, R Rosini, CL Galeotti, F Berti, F Necchi, V Reguzzi, ...
PLoS One 5 (2), e9216, 2010
1332010
Group B Streptococcus vaccine: state of the art
A Nuccitelli, CD Rinaudo, D Maione
Therapeutic Advances in Vaccines, 2051013615579869, 2015
1272015
Stringent control of gene expression in vivo by using novel doxycycline-dependent trans-activators
S Lamartina, G Roscilli, CD Rinaudo, E Sporeno, L Silvi, W Hillen, ...
Human gene therapy 13 (2), 199-210, 2002
1252002
Surfome Analysis as a Fast Track to Vaccine Discovery IDENTIFICATION OF A NOVEL PROTECTIVE ANTIGEN FOR GROUP B STREPTOCOCCUS HYPERVIRULENT STRAIN COH1
F Doro, S Liberatori, MJ Rodríguez-Ortega, CD Rinaudo, R Rosini, ...
Molecular & cellular proteomics 8 (7), 1728-1737, 2009
1222009
Sortase A utilizes an ancillary protein anchor for efficient cell wall anchoring of pili in Streptococcus agalactiae
AH Nobbs, R Rosini, CD Rinaudo, D Maione, G Grandi, JL Telford
Infection and immunity 76 (8), 3550-3560, 2008
1142008
Use of Lactococcus lactis expressing pili from group B Streptococcus as a broad-coverage vaccine against streptococcal disease
S Buccato, D Maione, CD Rinaudo, G Volpini, AR Taddei, R Rosini, ...
Journal of Infectious Diseases 194 (3), 331-340, 2006
1072006
Construction of an rtTA2s-M2/tTSkid-based transcription regulatory switch that displays no basal activity, good inducibility, and high responsiveness to doxycycline in mice and …
S Lamartina, L Silvi, G Roscilli, D Casimiro, AJ Simon, ME Davies, ...
Molecular Therapy 7 (2), 271-280, 2003
1002003
Capsular gene typing of Streptococcus agalactiae compared to serotyping by latex agglutination
K Yao, K Poulsen, D Maione, CD Rinaudo, L Baldassarri, JL Telford, ...
Journal of clinical microbiology 51 (2), 503-507, 2013
962013
Pilus backbone contributes to group B Streptococcus paracellular translocation through epithelial cells
A Pezzicoli, I Santi, P Lauer, R Rosini, D Rinaudo, G Grandi, JL Telford, ...
Journal of Infectious Diseases 198 (6), 890-898, 2008
932008
Hyaluronidase increases electrogene transfer efficiency in skeletal muscle
C Mennuni, F Calvaruso, I Zampaglione, G Rizzuto, D Rinaudo, ...
Human gene therapy 13 (3), 355-365, 2002
902002
Lipofection of purified adeno-associated virus Rep68 protein: toward a chromosome-targeting nonviral particle
S Lamartina, G Roscilli, D Rinaudo, P Delmastro, C Toniatti
Journal of virology 72 (9), 7653-7658, 1998
701998
Immunogenic compositions for gram positive bacteria such as streptococcus agalactiae
J Telford, G Grandi, P Lauer, M Mora, IY Ros, D Maione, G Bensi, ...
US Patent App. 11/192,046, 2005
452005
The system can't perform the operation now. Try again later.
Articles 1–20